Research and Markets: India Pharmaceutical Market Overview Growing Economic Wealth Fuels Pharma Market Growth, But Generics Dominate

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/89000c/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Market Overview Growing economic wealth fuels pharma market growth, but generics dominate" report to their offering.

“India Pharmaceutical Market Overview Growing economic wealth fuels pharma market growth, but generics dominate”

The prescription pharmaceutical market in India generated $7.1 billion in sales in 2009, with an annual growth rate of 18.1% between 2008 and 2009. Key growth drivers include India's growing economy, low operating costs, expanding health insurance coverage and healthcare expenditure especially among the middle classes. It is an overview of the Indian pharmaceutical market including socioeconomic trends, regulatory issues, market sizing, expiry analysis and drug infrastructure analysis

Scope:

• Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property position in India
• Assesses the size of the Indian pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies
• Examines the Indian generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion
• Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

Highlights:

• India's expanding and aging population, together with its growing economic wealth are driving drug expenditure, a trend which is putting pressure on the government to provide better healthcare services a move which will further stimulate pharma market growth.
• However, until government efforts to improve healthcare coverage for the poor are expanded, most drug expenditure will be derived from the upper and middle classes who are increasingly suffering from Western type of diseases and are turning towards foreign branded drugs.
• Domestic manufacturers dominate the Indian pharmaceutical market, with generics accounting for over 99% of the total market volume and 20% of market value. Despite market saturation, uptake is and will continue to be driven primarily by the growing number of patients gaining access to affordable medicines, with branding critical for success.

Reasons to Purchase:

• Evaluate the evolving regulatory landscape and the impact of expanding healthcare coverage on market access in India
• Quantify the size and growth of the prescription pharmaceutical market in India, analyzing key therapy areas, brands and companies
• Assess drivers and resistors of generic and biosimilars uptake in India

Key Topics Covered:

• India - Executive Summary
• India - Socio-demographic and economic analysis
• India - Healthcare system and drug regulatory analysis
• India - Prescription pharmaceutical sales analysis
• India - Drug expiry analysis
• India - Pharmaceutical Industry Infrastructure analysis
• Bibliography

For more information visit http://www.researchandmarkets.com/research/89000c/india_pharmaceutic

Source: Datamonitor